Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis.
Tsao, Che-kai
Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis. [electronic resource] - World journal of urology Dec 2013 - 1535-9 p. digital
Publication Type: Journal Article
1433-8726
10.1007/s00345-012-1001-3 doi
Aged
Carcinoma, Renal Cell--drug therapy
Cohort Studies
Enzyme Inhibitors--therapeutic use
Female
Humans
Kidney Neoplasms--drug therapy
Logistic Models
Male
Middle Aged
Molecular Targeted Therapy--trends
Neoplasm Staging
Nephrectomy--methods
Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors
Registries
Retrospective Studies
SEER Program--statistics & numerical data
Treatment Outcome
United States
Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis. [electronic resource] - World journal of urology Dec 2013 - 1535-9 p. digital
Publication Type: Journal Article
1433-8726
10.1007/s00345-012-1001-3 doi
Aged
Carcinoma, Renal Cell--drug therapy
Cohort Studies
Enzyme Inhibitors--therapeutic use
Female
Humans
Kidney Neoplasms--drug therapy
Logistic Models
Male
Middle Aged
Molecular Targeted Therapy--trends
Neoplasm Staging
Nephrectomy--methods
Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors
Registries
Retrospective Studies
SEER Program--statistics & numerical data
Treatment Outcome
United States